The Changing Dynamics Of The Pharma/Biotech Supply Chain – A Packaging And Clinical Supply Perspective

Perhaps more than any other industry, pharma and biotech have undergone radical change over the past year as a result of the COVID-19 pandemic. From supply chain security and capacity to clinical trial operations and site auditing – almost every aspect of the sector has been affected.

However, there was a feeling of ‘business as usual’ in some areas as pressures to launch products quickly, deliver more efficient and agile packaging solutions and meet the growing demand for capacities in the biotech sector remained.

Here, experts from Sharp explore how these trends are shaping the industry.